290 related articles for article (PubMed ID: 28007570)
41. A fatty gut feeling.
Piomelli D
Trends Endocrinol Metab; 2013 Jul; 24(7):332-41. PubMed ID: 23567058
[TBL] [Abstract][Full Text] [Related]
42. An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism.
Meziane H; Schaller F; Bauer S; Villard C; Matarazzo V; Riet F; Guillon G; Lafitte D; Desarmenien MG; Tauber M; Muscatelli F
Biol Psychiatry; 2015 Jul; 78(2):85-94. PubMed ID: 25599930
[TBL] [Abstract][Full Text] [Related]
43. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation.
Campolongo P; Roozendaal B; Trezza V; Cuomo V; Astarita G; Fu J; McGaugh JL; Piomelli D
Proc Natl Acad Sci U S A; 2009 May; 106(19):8027-31. PubMed ID: 19416833
[TBL] [Abstract][Full Text] [Related]
44. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
[TBL] [Abstract][Full Text] [Related]
45. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
Fu J; Gaetani S; Oveisi F; Lo Verme J; Serrano A; Rodríguez De Fonseca F; Rosengarth A; Luecke H; Di Giacomo B; Tarzia G; Piomelli D
Nature; 2003 Sep; 425(6953):90-3. PubMed ID: 12955147
[TBL] [Abstract][Full Text] [Related]
46. Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine.
Fu J; Dipatrizio NV; Guijarro A; Schwartz GJ; Li X; Gaetani S; Astarita G; Piomelli D
J Neurosci; 2011 Apr; 31(15):5730-6. PubMed ID: 21490214
[TBL] [Abstract][Full Text] [Related]
47. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
48. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
[TBL] [Abstract][Full Text] [Related]
49. The imprinted gene Magel2 regulates normal circadian output.
Kozlov SV; Bogenpohl JW; Howell MP; Wevrick R; Panda S; Hogenesch JB; Muglia LJ; Van Gelder RN; Herzog ED; Stewart CL
Nat Genet; 2007 Oct; 39(10):1266-72. PubMed ID: 17893678
[TBL] [Abstract][Full Text] [Related]
50. Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice.
Mercer RE; Wevrick R
PLoS One; 2009; 4(1):e4291. PubMed ID: 19172181
[TBL] [Abstract][Full Text] [Related]
51. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.
Gaetani S; Fu J; Cassano T; Dipasquale P; Romano A; Righetti L; Cianci S; Laconca L; Giannini E; Scaccianoce S; Mairesse J; Cuomo V; Piomelli D
J Neurosci; 2010 Jun; 30(24):8096-101. PubMed ID: 20554860
[TBL] [Abstract][Full Text] [Related]
52. Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.
Maillard J; Park S; Croizier S; Vanacker C; Cook JH; Prevot V; Tauber M; Bouret SG
Hum Mol Genet; 2016 Aug; 25(15):3208-3215. PubMed ID: 27288456
[TBL] [Abstract][Full Text] [Related]
53. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.
Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y
Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the hypothalamic oxytocin system and oxytocin receptor-expressing astrocytes in a mouse model of Prader-Willi syndrome.
Althammer F; Wimmer MC; Krabichler Q; Küppers S; Schimmer J; Fröhlich H; Dötsch L; Gruber T; Wunsch S; Schubert T; Kirchner MK; Stern JE; Charlet A; Grinevich V; Schaaf CP
J Neuroendocrinol; 2022 Dec; 34(12):e13217. PubMed ID: 36458331
[TBL] [Abstract][Full Text] [Related]
55. Magel2 is required for leptin-mediated depolarization of POMC neurons in the hypothalamic arcuate nucleus in mice.
Mercer RE; Michaelson SD; Chee MJ; Atallah TA; Wevrick R; Colmers WF
PLoS Genet; 2013; 9(1):e1003207. PubMed ID: 23341784
[TBL] [Abstract][Full Text] [Related]
56. Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production.
Chen H; Victor AK; Klein J; Tacer KF; Tai DJ; de Esch C; Nuttle A; Temirov J; Burnett LC; Rosenbaum M; Zhang Y; Ding L; Moresco JJ; Diedrich JK; Yates JR; Tillman HS; Leibel RL; Talkowski ME; Billadeau DD; Reiter LT; Potts PR
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32879135
[TBL] [Abstract][Full Text] [Related]
57. Cellular and disease functions of the Prader-Willi Syndrome gene
Tacer KF; Potts PR
Biochem J; 2017 Jun; 474(13):2177-2190. PubMed ID: 28626083
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
[TBL] [Abstract][Full Text] [Related]
59. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.
Wang X; Miyares RL; Ahern GP
J Physiol; 2005 Apr; 564(Pt 2):541-7. PubMed ID: 15695242
[TBL] [Abstract][Full Text] [Related]
60. Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus.
Ren T; Liu J; Ge Y; Zhuo R; Peng L; Liu F; Jin X; Yang L
Neurochem Int; 2019 Oct; 129():104501. PubMed ID: 31299417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
